Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xemed
Durham, New Hampshire, United Statesxemed.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Xemed develops inhaled diagnostic agents based on hyperpolarized noble gases—primarily xenon‑129—for advanced MRI-based functional imaging of the lungs. Their lead product, MagniXene®, enables high-resolution mapping of lung ventilation and microstructure to improve diagnosis and management of respiratory diseases such as COPD, asthma, IPF, CF, and BPD. The technology also serves as a tool for pharmaceutical companies to evaluate new therapies in clinical trials by providing quantitative endpoints related to lung function. The company has completed multiple early-phase studies at leading US centers and continues regulatory advancement toward broader commercial availability.
- Therapeutic areas
- Pulmonology
- Modalities
- Contrast agentDevice
- Industry
- Medical Imaging
02
Partnerships
Collaborations with major academic medical centers including Harvard University/Massachusetts General HospitalUniversity of Virginia Health SystemPartnerships with pharmaceutical companies validating new pulmonary drugs using their technology platform
Beyond the preview
Go deeper on Xemed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xemed.